A Section 319 public health emergency is a formal determination by the Secretary of Health and Human Services, under Section 319 of the Public Health Service Act (42 U.S.C. ยง 247d), that a disease, disorder, or other threat endangers the population. The declaration unlocks federal funding, triggers regulatory waivers, and allows rapid deployment of personnel and medical supplies. It lasts 90 days, can be renewed indefinitely, and shifts the federal government from routine health oversight into active crisis response.
When the Secretary Can Declare One
The statute gives the Secretary two grounds for a declaration: when a disease or disorder itself presents a public health emergency, and when a public health emergency otherwise exists, including significant outbreaks of infectious disease or bioterrorist attacks. There is no case count or mortality threshold. The Secretary has broad discretion to evaluate the situation and act.
Before making a determination, the Secretary must consult with public health officials as necessary. That generally means drawing on epidemiological data from the CDC and other federal agencies to judge how fast a threat is spreading and whether existing medical capacity can absorb it. Once the Secretary concludes the criteria are met, the declaration takes effect immediately.
The range of qualifying events is broader than most people assume. HHS Secretaries have invoked Section 319 for infectious disease outbreaks including COVID-19, H1N1 influenza, Zika, Ebola, and mpox, and for natural disasters including hurricanes, wildfires, flooding, and earthquakes. The nationwide opioid crisis has been continuously renewed under Section 319 since the original determination in October 2017, most recently in March 2026.
How Long a Declaration Lasts
A Section 319 declaration runs for 90 days from the date the Secretary signs it. The Secretary can terminate it early if the threat has passed, or extend it for additional 90-day periods if the emergency persists. There is no cap on renewals. The COVID-19 PHE was renewed thirteen times over more than three years before it ended in May 2023.
Every declaration and every extension requires notification to Congress within 48 hours. That is the primary check on the executive branch’s use of this authority. Separate reporting obligations apply to specific emergency actions: extensions or waivers of data-reporting deadlines must be published in the Federal Register, and deployments from the Strategic National Stockpile trigger 30-day recurring reports to Congress that continue until the PHE expires. Because a PHE can last years, Congress built in layered visibility.
What Powers a Declaration Unlocks
The declaration is a gateway. On its own it changes little; its value is in the authorities it activates.
The Public Health Emergency Fund
A declaration opens access to the Public Health Emergency Fund, a Treasury account the Secretary can spend from without the usual fiscal-year limitations and without waiting for a new appropriation. The Secretary can enter contracts and award grants to state and local health departments, private entities, and research institutions. Typical uses include expanding testing capacity, administering vaccines, investigating biological or environmental causes, tracking how a pathogen spreads, and procuring medical supplies and laboratory equipment at a speed standard federal purchasing cannot match.
Emergency Use Authorizations
Under Section 564 of the Federal Food, Drug, and Cosmetic Act, an EUA lets the FDA authorize drugs, biological products, and medical devices that have not completed the standard approval process, once the agency judges that known and potential benefits outweigh known and potential risks in the emergency context. This is how COVID-19 vaccines, therapeutics, and diagnostic tests reached the public well before full approval.
Worth noting for anyone tracking the two authorities: a formal Section 319 declaration is no longer a prerequisite for the Secretary’s EUA determination. The Secretary can independently find that a public health emergency or significant potential for one exists, which lets the FDA authorize products before a Section 319 declaration is in place.
PREP Act Liability Protections
The Public Readiness and Emergency Preparedness Act authorizes the Secretary to issue a separate declaration granting broad immunity from suit to those who develop, distribute, or administer a covered countermeasure such as a vaccine, drug, or diagnostic device. A PREP Act declaration is legally distinct from a Section 319 PHE, though the two often overlap.
Once a PREP Act declaration is in force, covered persons are immune under both federal and state law from claims arising from administration or use of the specified countermeasure. Immunity extends to manufacturers, distributors, program planners, and individual healthcare workers. The only exception is willful misconduct, meaning an intentional act taken without legal justification and in disregard of an obvious, serious risk. Individuals injured by a covered countermeasure have one exclusive remedy: the Countermeasures Injury Compensation Program, with claims due within one year of administration.
Section 1135 Regulatory Waivers
The most significant regulatory waivers, those affecting Medicare, Medicaid, and CHIP, require a second legal trigger. Under Section 1135 of the Social Security Act, the Secretary can waive or modify program requirements only when the President has also declared an emergency or disaster under the Stafford Act or the National Emergencies Act. Both declarations must be in place.
When both are active, available waivers include:
- Sanctions under the physician self-referral (Stark) law, so hospitals and physician groups can coordinate care and share resources without triggering anti-kickback penalties.
- State licensure requirements, so a physician or other professional licensed in one state can treat patients in the emergency area and still receive Medicare, Medicaid, and CHIP reimbursement.
- Specific HIPAA privacy provisions, such as the requirement to obtain a patient’s agreement before speaking with family members or to honor requests to opt out of facility directories.
Section 1135 waivers apply to specific geographic areas or provider groups directly affected. They end when either declaration ends, or 60 days after the waiver is first published, whichever comes first, subject to 60-day extensions.
Telehealth Prescribing of Controlled Substances
The Ryan Haight Act normally requires an in-person medical evaluation before a practitioner can prescribe Schedule II through V controlled substances by telemedicine. That requirement was suspended during the COVID-19 PHE. Even after the PHE ended in May 2023, the DEA and HHS have repeatedly extended the flexibility. The fourth extension, published in the Federal Register in late 2025, allows DEA-registered practitioners to prescribe controlled substances by telemedicine without a prior in-person visit through December 31, 2026. The practitioner must still prescribe for a legitimate medical purpose, use an interactive telecommunications system, and hold the appropriate DEA registration for the class of substance.
How Section 319 Fits with Stafford Act Declarations
Section 319 is a health-specific authority. It is declared unilaterally by the HHS Secretary and focuses on public health response: grants, investigations, medical personnel, testing, vaccination. A Stafford Act declaration is different in every dimension. It requires a request from a state governor or tribal leader and a presidential determination, and FEMA then coordinates financial and logistical support for response, recovery, and mitigation, including costs like activating state emergency operations centers and deploying the National Guard.
The federal government routinely invokes both at once. During COVID-19, FEMA provided a 75 percent federal cost share for disaster-related expenses alongside the health-focused response coordinated through HHS. For providers and state officials, the practical consequence is overlapping federal programs with different eligibility rules, reimbursement timelines, and reporting requirements. Knowing which authority governs which resource matters for the finances of any response.
What Ends When the Declaration Ends
Termination is not administrative housekeeping. It sets off a cascade.
Section 1135 waivers expire. Healthcare providers must immediately resume compliance with Stark Law referral restrictions, standard HIPAA privacy procedures, and state licensure requirements. CMS and the HHS Office of Inspector General confirmed during the COVID-19 wind-down that enforcement discretion ends when the waivers do.
Products authorized under EUAs enter a transition period. The FDA’s framework requires manufacturers to either obtain standard marketing authorization or discontinue distribution once the relevant EUA declaration is no longer in effect. For diagnostic tests, treatments, and devices that entered the market solely under an EUA, the end of the emergency starts a regulatory clock.
Program-level consequences can be the largest. During the COVID-19 PHE, the Families First Coronavirus Response Act conditioned a 6.2 percentage-point increase in the federal Medicaid matching rate on states maintaining continuous enrollment of nearly all Medicaid beneficiaries. When the continuous enrollment condition ended on March 31, 2023, states began large-scale eligibility redeterminations, and millions lost Medicaid coverage. SNAP emergency allotments followed a similar pattern: the Consolidated Appropriations Act of 2023 ended federal authorization for the supplemental benefits effective March 2023.
The recurring lesson from major PHE wind-downs is that the emergency authorities build dependencies. Healthcare systems adjust staffing, billing, and care delivery around the flexibilities. Patients come to rely on expanded benefits. When the declaration ends, those adjustments have to be unwound, often on compressed timelines and at significant administrative cost.